Agneta Zickert

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. 2024;:hcae052

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection

Nln I; Shum J; Ghodke-Puranik Y; Tipon R; Triese D; Amin S; Makol A; Osborn T; Chowdhary V; Thanarajasingam U; Muskardin TLW; Oke V; Gunnarsson I; Zickert A; Zervou MI; Boumpas DT; Svenungsson E; Goulielmos GN; Niewold TB
Article: ARTHRITIS RESEARCH & THERAPY. 2024;26(1):65

Low CD4+T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Roennblom L; Pihl S; Saleh M; Sjoewall C; Strevens H; Joensen A; Bengtsson AA; Trysberg E; Majczuk Sennstroem M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell A-C
Article: CLINICAL RHEUMATOLOGY. 2023;42(11):2981-2986

Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study

Karlsson L; Zickert A; Svenungsson E; Schmidt-Mende J; Faustini F; Gunnarsson I
Article: CLINICAL RHEUMATOLOGY. 2023;42(10):2889-2895

Occurrence and localization of FOXP3+cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis

Zickert A; Jankovic MR; Malmstrom V; Chemin K; Gunnarsson I
Article: ARTHRITIS RESEARCH & THERAPY. 2023;25(1):107

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus

Torell A; Stockfelt M; Larsson G; Blennow K; Zetterberg H; Leonard D; Roennblom L; Saleh M; Sjowall C; Strevens H; Jonsen A; Bengtsson AA; Trysberg E; Sennstrom MM; Zickert A; Svenungsson E; Gunnarsson I; Christenson K; Bylund J; Jacobsson B; Rudin A; Lundell A-C
Article: RHEUMATOLOGY. 2023;62(2):924-933

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE

Elbagir S; Diaz-Gallo L-M; Grosso G; Zickert A; Gunnarsson I; Mahler M; Svenungsson E; Ronnelid J
Article: LUPUS SCIENCE & MEDICINE. 2022;9(1):e000744

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis

Hayry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
Article: ACR OPEN RHEUMATOLOGY. 2022;4(1):27-39

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations

Diaz-Gallo L-M; Oke V; Lundstrom E; Elvin K; Wu YL; Eketjall S; Zickert A; Gustafsson JT; Jonsen A; Leonard D; Birmingham DJ; Nordmark G; Bengtsson AA; Ronnblom L; Gunnarsson I; Yu C-Y; Padyukov L; Svenungsson E
Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(10):1299-1309

The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies

Grosso G; Sandholm K; Antovic A; Gunnarsson I; Zickert A; Vikerfors A; Truedsson L; Bruzelius M; Nilsson B; Nilsson-Ekdahl K; Svenungsson E
Article: LUPUS SCIENCE & MEDICINE. 2021;8(1):e000515

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study

Samuelsson I; Parodis I; Gunnarsson I; Zickert A; Hofman-Bang C; Wallen H; Svenungsson E
Article: LUPUS. 2021;30(8):1289-1299

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE

Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Ronnelid J; Svenungsson E
Article: RHEUMATOLOGY. 2021;60(7):3443-3450

Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment

Zickert A; Lannfelt K; Mende JS; Sundelin B; Gunnarsson I
Article: LUPUS SCIENCE & MEDICINE. 2021;8(1):e000463

Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies

Stockfelt M; Larsson G; Engstrom H; Puttonen H; Zetterberg H; Blennow K; Sjowall C; Strevens H; Jonsen A; Bengtsson AA; Sennstrom MM; Zickert A; Svenungsson E; Gunnarsson I; Trysberg E; Jacobsson B; Ekwall A-KH; Christenson K; Bylund J; Svensson MND; Lundell A-C
Article: RHEUMATOLOGY. 2020;59(9):2237-2249

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus

Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Alves CS; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
Article: JOURNAL OF RHEUMATOLOGY. 2020;47(6):865-875

Sjogren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State

Ruacho G; Kvarnstrom M; Zickert A; Oke V; Ronnelid J; Eketjall S; Elvin K; Gunnarsson I; Svenungsson E
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020;21(10):E3463-3463

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

Parodis I; Akerstrom E; Sjowall C; Sohrabian A; Jonsen A; Gomez A; Frodlund M; Zickert A; Bengtsson AA; Roennelid J; Gunnarsson I
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:582737

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients

Martin M; Trattner R; Nilsson SC; Bjork A; Zickert A; Blom AM; Gunnarsson I
Article: BIOLOGY OF SEX DIFFERENCES. 2019;10(1):60

Sex differences in clinical presentation of systemic lupus erythematosus

Sepulveda JIR; Bolin K; Mofors J; Leonard D; Svenungsson E; Jonsen A; Bengtsson C; Nordmark G; Dahlqvist SR; Bengtsson AA; Ronnblom L; Sjowall C; Gunnarsson I; Wahren-Herlenius M; Zickert A; Bjork A; Jonsen A; Sjowali C; Enocsson H; Wettero J; Eriksson P; Thorlacius GE; Lundberg IE; Sanding JK; SeNiveda JIR; Lindblad-Toh K; Ronnblom L; Padyukov L; Hultin-Rosenberg L; Eloranta M-L; Dahiqvist SR
Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):259

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Sohrabian A; Parodis I; Carlstromer-Berthen N; Frodlund M; Jonsen A; Zickert A; Sjowall C; Bengtsson AA; Gunnarsson I; Ronnelid J
Article: ARTHRITIS CARE & RESEARCH. 2019;71(6):811-821

The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With SystemicLupus Erythematosus

Parodis I; Benavides AHL; Zickert A; Pettersson S; Moller S; Henriksson EW; Voss A; Gunnarsson I
Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):107

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

Oke V; Gunnarsson I; Dorschner J; Eketjaell S; Zickert A; Niewold TB; Svenungsson E
Article: KIDNEY INTERNATIONAL. 2019;95(3):655-665

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis

Wilson HR; Medjeral-Thomas NR; Gilmore AC; Trivedi P; Seyb K; Farzaneh-Far R; Gunnarsson I; Zickert A; Cairns TD; Lightstone L; Cook HT; Pickering MC
Article: EBIOMEDICINE. 2019;40:517-527

B cell alterations during BAFF inhibition with belimumab in SLE

Ramskold D; Parodis I; Lakshmikanth T; Sippl N; Khademi M; Chen Y; Zickert A; Mikes J; Achour A; Amara K; Piehl F; Brodin P; Gunnarsson I; Malmstrom V
Article: PLOS ONE. 2019;14(2):e0212068

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis

Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Gronwall C; Mohan C; Gunnarsson I
Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(8):911-920

Smoking reduces the efficacy of belimumab in mucocutaneous lupus

Parodis I; Gomez A; Frodlund M; Jonsen A; Zickert A; Sjowall C; Bengtsson AA; Gunnarsson I
Article: LUPUS. 2018;27(9):1470-1478

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL

Parodis I; Soder F; Faustini F; Kasza Z; Samuelsson I; Zickert A; Svenungsson E; van Vollenhoven RF; Malmstrom V; Wermeling F; Gunnarsson I
Article: ATHEROSCLEROSIS. 2018;270:1-7

Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis

Wigren M; Svenungsson E; Mattisson IY; Gustafsson JT; Gunnarsson I; Zickert A; Elvin K; Jensen-Urstad K; Bengtsson A; Gullstrand B; Fredrikson GN; Nilsson J
Article: LUPUS SCIENCE & MEDICINE. 2018;5(1):e000260

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

Idborg H; Eketjall S; Pettersson S; Gustafsson JT; Zickert A; Kvarnstrom M; Oke V; Jakobsson P-J; Gunnarsson I; Svenungsson E
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(4):263-272

Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):139

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)

Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(6):1272-1279

Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis

Arnaud L; Nordin A; Lundholm H; Svenungsson E; Hellbacher E; Wikner J; Zickert A; Gunnarsson I
Article: SCIENTIFIC REPORTS. 2016;6:36025

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations

Mobarrez F; Vikerfors A; Gustafsson JT; Gunnarsson I; Zickert A; Larsson A; Pisetsky DS; Wallen H; Svenungsson E
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2016;45(6):684-690

Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.

Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Article: LUPUS SCIENCE & MEDICINE. 2016;3(1):e000170

Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Zickert A; Oke V; Parodis I; Svenungsson E; Sundström Y; Gunnarsson I
Article: PLOS ONE. 2016;11(6):e0158076

Antiphospholipid Antibodies in Lupus Nephritis

Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmstrom V; Svenungsson E; Gunnarsson I
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1537-1543

Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus

Gustafsson JT; Gunnarsson I; Kallberg H; Pettersson S; Zickert A; Vikerfors A; Moller S; Ronnelid J; Elvin K; Svenungsson E
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):109

Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up

Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Article: BMC IMMUNOLOGY. 2015;16(1):7

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment

Zickert A; Amoudruz P; Sundstrom Y; Ronnelid J; Malmstrom V; Gunnarsson I
Article: LUPUS SCIENCE & MEDICINE. 2015;2(1):e000061

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.

Parodis I; Zickert A; Sundelin B; Axelsson M; Gerhardsson J; Svenungsson E; Malmström V; Gunnarsson I
Article: LUPUS SCIENCE & MEDICINE. 2014;1(1):e000018

Role of early repeated renal biopsies in lupus nephritis.

Zickert A; Sundelin B; Svenungsson E; Gunnarsson I
Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(6):1018-1025

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus

Lundstrom E; Gustafsson JT; Jonsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Kallberg H; Sandling JK; Syvanen A-C; Klareskog L; Gunnarsson I; Ronnblom L; Padyukov L; Svenungsson E
Article: RHEUMATOLOGY. 2013;52(5):847-855

Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response

Jonsdottir T; Zickert A; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I
Article: RHEUMATOLOGY. 2013;52(3):501-509

Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays

Vikerfors A; Johansson A-B; Gustafsson JT; Jonsen A; Leonard D; Zickert A; Nordmark G; Sturfelt G; Bengtsson A; Ronnblom L; Gunnarsson I; Elvin K; Svenungsson E
Article: PLOS ONE. 2013;8(12):e84450

Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis

Bolin K; Sandling JK; Zickert A; Jonsen A; Sjowall C; Svenungsson E; Bengtsson AA; Eloranta M-L; Ronnblom L; Syvanen A-C; Gunnarsson I; Nordmark G
Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(1):R36

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis

Zickert A; Palmblad K; Sundelin B; Chavan S; Tracey KJ; Bruchfeld A; Gunnarsson I
Article: ARTHRITIS RESEARCH & THERAPY. 2011;13(6):r206

Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus

Jonsen A; Nilsson SC; Ahlqvist E; Svenungsson E; Gunnarsson I; Eriksson KG; Bengtsson A; Zickert A; Eloranta M-L; Truedsson L; Ronnblom L; Nordmark G; Sturfelt G; Blom AM
Article: LANCET. 2009;374(9688):459-466

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Coster L; Waltbrand E; Zickert A; Theander J; Thorner A; Hellstrom H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wornert M; Bratt J
Article: ARTHRITIS RESEARCH & THERAPY. 2009;11(6):R188

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis

Sjowall C; Zickert A; Skogh T; Wettero J; Gunnarsson I
Article: BIOCHEMICAL PHARMACOLOGY. 2000;59(8):1007-1013

No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions.

Asbrink S; Zickert A; Bratt J; Gyllenhammar H; Palmblad J
Visa fler

Alla övriga publikationer

Review: AUTOIMMUNITY REVIEWS. 2017;16(4):343-351

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

Parodis I; Sjowall C; Jonsen A; Ramskold D; Zickert A; Frodlund M; Sohrabian A; Arnaud L; Ronnelid J; Malmstrom V; Bengtsson AA; Gunnarsson I
Thesis / dissertation: 2013

Studies on lupus nephritis

Zickert, Agneta

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2013

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI